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Background: The ratio of the maximum diameter of consolidation to the maximum tumor diameter (C/T ratio)
on thin-section computed tomography (TSCT) and the maximum standardized uptake value (SUVmax) on
18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) are often used as
preoperative independent variables to evaluate the invasiveness of lung adenocarcinoma. We investigated the
associations between these independent variables and pathologic invasiveness in pulmonary adenocarcinomas.
Methods: We selected patients with peripheral lung adenocarcinomas, definitively diagnosed by surgical resection,
with diameters of ≤ 30 mm over a 4-year period ending in December 2010. The association between 3 independent
variables (tumor size, SUVmax, and C/T ratio) and pathologic prognostic factors was evaluated using logistic analysis.
Results: We evaluated a total of 163 primary lung adenocarcinomas in 148 patients (93 males and 55 females;
age range: 34 to 84 years). Using multivariate logistic regression analysis, SUVmax and the C/T ratio were significantly
associated with tumor invasiveness (odds ratio [OR] = 1.227; p = 0.025 and OR = 1.019; p = 0.008, respectively). Tumor
size was not associated with invasiveness (OR = 1.003; p = 0.925). For solid type adenocarcinomas, only SUVmax was
significantly associated with invasiveness (OR = 1.558; p = 0.003). For subsolid type adenocarcinomas, only the C/T ratio
was significantly associated with invasiveness (OR = 1.030; p = 0.009).
Conclusions: Both the C/T ratio and the SUVmax are significantly correlated with pathologic invasiveness in patients with
small lung adenocarcinomas, while there was a difference between the 2 evaluations. Solid type adenocarcinomas
with SUVmax values of ≥ 4.4 and subsolid type adenocarcinomas with C/T ratio ≥ 53% were so highly invasive.
Keywords: Lung neoplasms, Adenocarcinoma, Computed tomography, Positron emission tomography,
Fluorodeoxyglucose, Prognostic factorBackground
Adenocarcinoma is the most common pathological type
of peripheral lung cancer. However, even in patients
with tumors of ≤ 3 cm in diameter, the postoperative
prognosis varies, with poorly differentiated adenocarcinoma
demonstrating a poor prognosis. Therefore, the use of* Correspondence: iwano45@med.nagoya-u.ac.jp
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important, as limited resection (pulmonary segmentation
or wide wedge resection) is currently recommended for
non-invasive tumors [1-4].
Well-differentiated lung adenocarcinomas are often of a
subsolid type, generally indicating a non-invasive nature
and a good prognosis. These tumors may show ground-
glass opacity on thin-section computed tomography
(TSCT). On the other hand, poorly differentiated adeno-
carcinomas are usually of a solid type and have a tendencytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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consist entirely of consolidation on TSCT. This explains
the usefulness of the C/T ratio, the maximum diameter of
consolidation to the maximum tumor diameter on TSCT,
in predicting the invasiveness and prognosis in patients
with lung adenocarcinoma [1,3-7].
18F-fluorodeoxyglucose (FDG) positron emission tom-
ography/computed tomography (PET/CT) is also essential
in the preoperative evaluation of patients with primary
lung cancer. The maximum standardized uptake value
(SUVmax) of the primary lesion on PET/CT is well cor-
related with both tumor size and differentiation, with
high-grade tumors tending to have a high SUVmax [8-10].
As with the C/T ratio, this value is used to determine
tumor invasiveness and predict patient prognosis [11-18].
It is unclear whether the C/T ratio or the SUVmax value
is a more suitable preoperative independent variables
for predicting tumor invasiveness, or if there are any
differences between them. We therefore conducted a
retrospective investigation into the association between
each of these independent variables, along with tumor
size, and the pathologic invasiveness in patients with
small (≤3 cm) pulmonary adenocarcinomas. In addition,
we determined the most suitable independent variables
cutoff levels to predict tumor invasiveness.
Methods
This retrospective study was approved by the institutional
review board (IRB) of our hospital. The IRB waived the
need for written informed consent.
Patient selection
We searched our institution’s records from November
2006 to December 2010 and selected patients who had
preoperative PET/CT conducted for pulmonary tumors.
We then obtained the clinical records, preoperative TSCT
images, and postoperative pathological records for these
patients. We limited our study to patients with peripheral
lung adenocarcinomas of ≤ 30 mm in diameter that had
been definitively diagnosed by pathological examination
after surgical resection. We recorded the age, sex, and
body weight of all patients, the pathological findings of
the primary tumor (maximum diameter, lymph node
metastasis, lymphatic permeation, vascular invasion, and
pleural involvement) [17-20], and the pathological stage
based on the Union for International Cancer Control
guidelines, version 7.
Preoperative TSCT
All preoperative TSCT examinations were performed using
a 64- detector row scanner (Aquilion 64; Toshiba Medical
Systems Corp., Tokyo, Japan). All scans were obtained from
the lung apex to the diaphragm, during a breath-hold at
deep inspiration, using the following parameters: x-ray tubevoltage, 120 kVp; automatic tube-current maximum, 225
mAs; gantry rotation speed, 0.5 sec; and beam collimation,
64 × 0.5 mm. The TSCT images were reconstructed from
0.5-mm slices with intervals of 0.5 mm, using a high
spatial-frequency reconstruction algorithm (FC52). No
contrast medium was used.
Measurement of consolidation/tumor ratio (C/T ratio)
Two radiologists independently evaluated the TSCT im-
ages using lung-window settings (window level, −600
Hounsfield units; window width, 1,800 Hounsfield units).
The viewing monitor belonged to a picture archiving and
communication system (RapideyeCore, Toshiba Medical
Systems Corp., Tokyo, Japan). The radiologists calculated
the C/T ratio, defined as the maximum diameter of con-
solidation over the maximum tumor diameter (Figure 1)
[1,3-7]. The consolidation component was defined as an
area of increased opacification that completely obscured
the underlying vascular markings. Ground-glass opacity
was defined as an area of a slight, homogenous increase
in density that did not obscure the underlying vascular
markings. Areas of ground-glass opacity often present as
lepidic-predominant adenocarcinoma, typified by lepidic
growth along alveoli, without invasive areas. Previous
studies have shown that C/T ratio is related to aggressive-
ness and and prognosis in patients with lung adenocarcin-
oma. The mean value of the 2 observers for each tumor
was used for the study analyses to reduce measuring error.
We classified tumors into “solid type”, tumors containing
no ground-glass opacities (C/T ratio = 100%), and “subso-
lid type”, tumors containing any ground-glass opacity
(C/T ratio < 100%).
Preoperative PET/CT
All preoperative PET/CT examinations were made using
the Biograph 16 scanner (Siemens Medical Solutions,
Erlangen, Germany). Patients were required to fast for
at least 6 hours prior to imaging, and blood glucose
levels were measured immediately prior to injecting
FDG. Patients with blood glucose levels of >150 mg/dL
were excluded from the study [3,17]. The FDG dose
was determined by body weight, using either 3.7 MBq/kg
(for patients weighing < 60 kg) or 4.07 MBq/kg (for
patients weighing ≥ 60 kg). Fifty minutes after the intra-
venous injection of FDG, emission scans were acquired of
the area between the proximal femora and the base of the
skull; the 3-dimensional mode was used, with 1.7 min at
each bed position. Breath-holding and respiratory gating
were not used. PET images were reconstructed using
the ordered-subset expectation maximization (OSEM)
algorithm with 2 iterations and 16 subsets, incorporating
a CT-based transmission map. No contrast medium was
used for transmission CT according to the protocol of our
institution.
Figure 1 Example of the consolidation/tumor (C/T) ratio measurement on thin-section computed tomography. C/T ratio (%) =maximum
diameter of consolidation (black arrow)/maximum diameter of tumor (white arrow) × 100.
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(SUVmax)
The images were transferred to an e.soft Turbo-V work-
station (Siemens Medical Solutions) where fusion PET/
CT images were reconstructed. Regions of interest (ROIs)
were placed around the pulmonary lesions; the maximum
SUV value at a given ROI was defined as the SUVmax.
SUV ¼ ROI activity MBq=mLð Þ  body weight gð Þ
= injected FDG activity MBqð Þ
The SUVmax represents the maximum glucose meta-
bolic activity of the tumor.
Statistical analysis
First, the associations between the 3 independent variables
(tumor size, SUVmax, and C/T ratio) and the 3 pathologic
prognostic factors (pleural involvement, lymphatic/vascu-
lar invasion, and lymph node metastasis) were compared
using univariate logistic regression analysis. Pearson cor-
relation coefficients between C/T ratio versus tumor size,
SUVmax versus tumor size, and SUVmax versus C/T ratio
were determined. Next, we defined invasive adenocarcin-
omas as tumors that had at least one invasive pathologic
finding (pleural involvement, intratumoral vessel invasion,
or lymph node metastasis) and non-invasive adenocarcin-
omas as tumors that had no invasive pathologic findings
[6,7]. Multivariate logistic regression analysis was then
used to identify independent predictors of non-invasive or
invasive tumor nature, using the 6 independent variables
(age, body weight, blood sugar level, tumor size, SUVmax,
and C/T ratio) for all tumors, then separately for solid
type tumors and subsolid type tumors. The mean value
for each independent variables was compared, using
unpaired Student’s t-test, between non-invasive tumors
and invasive tumors. Patient characteristics (age, body
weight, and blood sugar level) and tumor characteristics(size, SUVmax, and C/T ratio) were compared between
the solid and subsolid groups using unpaired Student’s
t-test, and the frequency of pathological invasiveness
was compared between groups using the chi-square test.
Receiver operating characteristic (ROC) curve analysis
and Youden’s index were used to determine a cut-off level
that would indicate invasiveness for SUVmax in solid type
tumors and for the C/T ratio in subsolid type tumors
[21]. Finally, recurrence rates within 3 years after surgery
were compared using a Chi-square for independence test
between non-invasive tumors and invasive tumors.
Excel 2007 (Microsoft Corp., Redmond, WA) and Stat-
istical Package for the Social Sciences, version 21.0 (IBM
Corp., Armonk, NY), were used to conduct all statistical
analyses. A p-value of < 0.05 was considered significant.
Pearson correlation coefficients of > 0.4 were considered
as showing a positive correlation between variables.
Results
Study's cohort
Figure 2 shows this study’s cohort flow chart. A total of
148 patients (93 male and 55 female) were evaluated,
with an age range of 34 to 84 years and a median age of
68 years. These 148 patients had a total of 163 primary
lung adenocarcinomas (13 patients had 2 simultaneous
lesions and 1 patient had 3 lesions). There were a total of
51 lesions (31%) in the right upper lobe, 11 lesions (7%) in
the right middle lobe, 37 lesions (23%) in the right lower
lobe, 38 lesions (23%) in the left upper lobe, and 26 lesions
(16%) in the left lower lobe. The median maximum lesion
diameter was 19.0 mm. The mean ± standard deviation
(SD) C/T ratio was 76.3 ± 33.3%, with a intra-class cor-
relation coefficient between the 2 radiologists of 0.963
(95% confidential interval [CI] = 0.950 - 0.973, p < 0.001).
Eighty-two lesions were of the solid type and 81 were of
the subsolid type. The mean ± SD SUVmax was 2.8 ± 2.7.
Ninety-two lesions (56%) had an SUVmax of < 2.5, and
Figure 2 Study cohort flow chart. A total of 218 lung cancers
of ≤ 30 mm in diameter were found from PET/CT and clinical
records for a 4-year period. After exclusion, 163 adenocarcinomas
were included in our analysis.
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histological grade was G1 in 71 tumors, G2 in 76, G3
in 11, and GX (grade cannot be assessed) in 5 tumors.
Pleural involvement was observed in 70 lesions, intratu-
moral vessel invasion (lymphatic and/or vascular invasion)
in 24 lesions, and lymph node metastasis in 15 lesions.
Sixteen lesions had 2 invasive pathologic findings (pleural
involvement, intratumoral vessel invasion, or lymph node
metastasis) and 8 lesions had all 3 invasive pathologic
findings. Seventy-seven tumors (47%) were regarded as
invasive; these had at least 1 invasive pathologic finding.Table 1 Patient and tumor characteristics
Mean S
Patients
Age (years) 66 8
Body weight (kg) 57 1
Blood sugar (mg/dL) 93 1
Tumors
Size (mm) 18.8 6
SUVmax 2.8 2
C/T ratio (%) 76.3 3
SD: standard deviation; IQR: interquartile range; SUVmax: maximum standardized up
ND: not detectable.The remaining 86 tumors (53%) were regarded as non-
invasive. The pathological stage was stage I in 146 tumors,
stage II in 8, stage III in 8, and stage IV in 1 tumor.
The patient and tumor characteristics are summarized
in Table 1.
Association between the independent variables and each
pathologic prognostic factor
Table 2 shows the association between the independent
variables and the pathologic prognostic factors using uni-
variate logistic analysis. The tumor size was significantly
correlated with pleural involvement and lymph node
metastasis (p = 0.023 and p = 0.014, respectively), while
size was not correlated with intratumoral vessel invasion
(p = 0.158). The SUVmax was significantly correlated with
intratumoral vessel invasion, pleural involvement, and
lymph node metastasis (p < 0.001, p < 0.001, and p = 0.002,
respectively). The C/T ratio was significantly correlated
with intratumoral vessel invasion and pleural involvement
(p = 0.014 and p < 0.001, respectively), but not with lymph
node metastasis (p = 0.067). There was a positive correl-
ation between SUVmax values and C/T ratios (Pearson
correlation coefficient [r] = 0.48, p < 0.001). On the other
hand, there was weak correlation between SUVmax
and size (r = 0.36, p < 0.001); between C/T ratio and size
(r = 0.20, p = 0.011).
Association between the independent variables and the
tumor invasiveness
Table 3 shows the association between independent vari-
ables and tumor invasiveness using multivariate logistic
regression analysis. The SUVmax and C/T ratio were sig-
nificantly correlated with tumor invasiveness (p = 0.025
and p = 0.008, respectively), while tumor size was not
correlated with invasiveness (p = 0.925). For solid type
adenocarcinomas, multivariate logistic analysis demon-
strated that only SUVmax was significantly correlated
with invasiveness (p = 0.009). Conversely, in subsolid type
adenocarcinomas, only the C/T ratio was significantly
correlated with invasiveness (p = 0.003). Table 4 showsD Minimum IQR Maximum
34 62 - 73 84
1 36 49 - 63.5 80
4 61 84 - 101 141
.5 4 13.5 - 24 30
.7 ND 0.9 - 4.1 14.1
3.3 0 58.8 - 100 100
take value; C/T ratio: consolidation diameter/tumor diameter ratio;
Table 2 Univariate analyses for independent variables and pathologic prognostic factors
Pleural involvement Intratumoral vessel invasion Lymph node metastasis
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Size 1.060 (1.008-1.115) 0.023 1.052 (0.981-1.128) 0.158 1.130 (1.025-1.247) 0.014
SUVmax 1.290 (1.119-1.487) < 0.001 1.379 (1.176-1.616) < 0.001 1.293 (1.096-1.527) 0.002
C/T ratio 1.023 (1.010-1.035) < 0.001 1.073 (1.014-1.135) 0.014 1.032 (0.998-1.067) 0.067
OR: odds ratio; CI: confidence interval; SUVmax: maximum standardized uptake value; C/T ratio: consolidation diameter/tumor diameter ratio.
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adenocarcinomas. Solid type tumors had a significantly
higher rate of pleural involvement and intratumoral
vessel invasion than subsolid type tumors.
The invasive tumors demonstrated a significantly larger
size than non-invasive tumors (p = 0.016), and higher
values for SUVmax and the C/T ratio (p < 0.001 and
p < 0.001, respectively) (Table 5).
A suitable cutoff value for determining invasiveness
In the analysis of solid type adenocarcinomas, the results
of the ROC analysis for SUVmax showed an area under
the curve (AUC) of 0.727 (95% CI = 0.618-0.836). A suitable
cutoff value for determining invasiveness was estimated to
be 4.4. This value yielded a sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) for tumor invasiveness of 55%, 88%, 84% and
55%, respectively. In the analysis of subsolid type adeno-
carcinomas, the results for the C/T ratio showed an AUC
of 0.736 (95% CI = 0.618-0.852). A suitable cutoff value for
determining invasiveness was estimated to be 53%. This
value yielded a sensitivity, specificity, PPV, and NPV of
89%, 64%, 57% and 92%, respectively.
Postoperative outcomes
Table 6 shows the postoperative outcomes for 125 patients
with solitary lung adenocarcinomas. Twenty patients with
simultaneous and metachronous multiple lung cancers
were excluded from this analysis. Three patients were
also excluded because they changed to another hospital
within 3 years after surgery. Invasive adenocarcionomas
showed a significantly higher recurrence rate than did
non-invasive tumors (25% versus 6%, p = 0.004). Moreover,Table 3 Multivariate logistic regression analysis for independ
All (n = 163) Su
OR (95% CI) p-value OR (95%
Age 1.033 (0.988-1.080) 0.158 0.982 (0
Body weight 0.996 (0.963-1.029) 0.798 0.998 (0
Blood sugar 0.982 (0.956-1.010) 0.202 0.952 (0
Size 1.003 (0.944-1.066) 0.925 1.032 (0
SUVmax 1.227 (1.026-1.469) 0.025 0.880 (0
C/T ratio 1.019 (1.005-1.034) 0.008 1.030 (1
OR: odds ratio; CI: confidence interval; SUVmax: maximum standardized uptake valuno local recurrence or distant metastases were found in
16 patients who had limited resections for non-invasive
tumors. In contrast, a case of T1N0 invasive adenocar-
cinoma with intratumoral lymphatic permeation relapsed
in a mediastinal lymph node after segmentectomy. This
lesion was 13 mm in diameter, solid type (C/T ratio =
100%), and had a SUVmax of 4.8.
Eight of 90 (9%) patients who had a SUVmax of <4.4
relapsed after surgery, while 15 of 35 (43%) patients who
had a SUVmax of ≥ 4.4 relapsed. No local recurrence or
distant metastases were found in 21 patients who had a
C/T ratio <53%.
Discussion
We were able to clarify several points in this study. First,
both the C/T ratio (on TSCT) and the SUVmax (on
PET/CT) are significantly correlated with invasiveness in
patients with small adenocarcinomas. Next, an important
difference exists between the C/T ratio and the SUVmax
value: the C/T ratio is useful for predicting invasiveness
only in subsolid type adenocarcinomas, while the SUV-
max is suitable for solid type tumors. Finally, the cutoff
C/T ratio for determining invasiveness in subsolid type
adenocarcinomas is around 53%, while the cutoff for
SUVmax in solid type adenocarcinomas is around 4.4.
The ability to identify prognostic pathologic factors
on preoperative diagnostic imaging is essential to the
determination of appropriate therapeutic strategies. Most
small pulmonary adenocarcinomas are treated with pul-
monary lobectomy, however, there has been a recent
call to expand the indications for limited resection (e.g.,
segmentectomy or wide wedge resection) because of
the advantage to the patient in preserving pulmonaryent variables and tumor invasiveness
bsolid type (n = 81) Solid type (n = 82)
CI) p-value OR (95% CI) p-value
.913-1.056) 0.627 1.069 (1.000-1.142) 0.050
.950-1.048) 0.930 1.009 (0.957-1.063) 0.746
.912-0.994) 0.024 1.027 (0.979-1.077) 0.279
.939-1.135) 0.511 0.988 (0.899-1.086) 0.798
.636-1.217) 0.439 1.558 (1.157-2.099) 0.003
.007-1.053) 0.009 NA NA
e; C/T ratio: consolidation diameter/tumor diameter ratio; NA: not available.
Table 4 Comparisons between solid type and subsolid type adenocarcinomas
Subsolid type (n = 81) Solid type (n = 82) p-value
Age (years) 66 ± 7 66 ± 9 0.951
Body weight (kg) 56 ± 10 59 ± 10 0.052
Blood sugar (mg/dL) 94 ± 16 92 ± 11 0.359
Size (mm) 19.0 ± 6.7 18.6 ± 6.2 0.737
SUVmax 1.7 ± 2.0 3.8 ± 2.9 < 0.001
C/T ratio (%) 52.3 ± 33.1 100.0 ± 0.0 < 0.001
Pleural involvement (n) 27 (33%) 43 (52%) 0.014
Intratumor vessel invasion (n) 4 (5%) 20 (24%) < 0.001
Lymph node metastasis (n) 6 (7%) 9 (11%) 0.431
Invasive tumor (n) 28 (35%) 49 (60%) 0.001
SUVmax: maximum standardized uptake value; C/T ratio: consolidation diameter/tumor diameter ratio.
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locoregional recurrence due to the possibility of inadequate
surgical margins and incomplete lymph-node clearance
[1,22-24]. Therefore, to reduce risk to patients, it is very
important to be able to determine preoperatively which
tumors are likely to be non-invasive [2-4]. In the present
study, a case of adenocarcinoma with a high C/T ratio and
a high SUVmax value relapsed after segmentectomy. Our
results demonstrate that both TSCT and PET/CT findings
may be useful in deciding which patients are better suited
for limited resection.
We found that the SUVmax was significantly corre-
lated with all pathologic prognostic factors; in other
words, patients with higher SUVmax values have more
highly invasive tumors. The C/T ratio was also significantly
correlated with pleural involvement and intratumoral vessel
invasion, but not with lymph node metastasis. A higher
C/T ratio indicates that the tumor is associated with a
greater amount of consolidation, and these tumors
are more highly invasive. The reason that lymph node
metastasis did not show an association with the C/T
ratio in this study may have been because the absolute
number of lymph node metastases was small (n = 15).
In the present study, we selected lung adenocarcin-
omas of ≤ 3 cm in diameter, that is, T1a-b in the TNM
staging system by reference to the study of Asamura et al.Table 5 Comparisons between non-invasive and invasive ade
Non-invasive (n = 86)
Age (years) 65 ± 8
Body weight (kg) 56.8 ± 10.7
Blood sugar (mg/dL) 95.7 ± 14.9
Size (mm) 17.8 ± 6.7
SUVmax 1.86 ± 1.80
C/T ratio (%) 65.1 ± 37.7
SUVmax: maximum standardized uptake value; C/T ratio: consolidation diameter/tu
Values are means ± standard deviations.[4]. They reported a C/T ratio 0.25 or less in cT1a
(≤2 cm) and 0.05 in cT1a-b (≤3 cm) were both able to
define a homogenous group of patients with an excellent
prognosis. In our study, tumor size is correlated with
pleural involvement and lymph node metastasis, but not
with intratumoral vessel invasion. Multivariate analysis
showed that both the C/T ratio and the SUVmax value
are independent and significant variables for predicting
the invasiveness of lung adenocarcinoma, but tumor size
is not significant. The C/T ratio and the SUVmax value
may provide valuable information about tumor differenti-
ation in small adenocarcinomas.
Next, we classified adenocarcinomas into solid type and
subsolid type. The solid type tumors all have a C/T ratio
of 100%, consisting only of consolidation, and therefore
the C/T ratio cannot be used to predict invasiveness in
this group. SUVmax is a significant independent variable
for invasiveness in patients with solid type tumors, but
only the C/T ratio is independently correlated with
invasiveness in those with subsolid type tumors. We
suggest, based on these results, that the C/T ratio
should be evaluated first, and SUVmax should be used
to predict invasiveness and prognosis only in patients
with solid type tumors.
Finally, we evaluated suitable cutoff values for predicting
invasiveness in both the solid- and subsolid types ofnocarcinomas
Invasive (n = 77) p-value
67 ± 8 0.184
57.4 ± 10.3 0.704
91.0 ± 12.5 0.031
20.0 ± 6.0 0.016
3.80 ± 3.10 < 0.001
88.9 ± 22.0 < 0.001
mor diameter ratio.
Table 6 Postoperative outcomes with solitary lung adenocarcinomas
Total (n) Recurrence within 3 years (n) Recurrence rate (%)
Invasive 61 15 25
Lobectomy 54 14 26
Limited resection 7 1 14
Non-invasive 64 4 6
Lobectomy 48 4 8
Limited resection 16 0 0
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type tumors. SUVmax is correlated with both tumor size
and histopathologic characteristics, with well-differentiated
adenocarcinomas demonstrating low SUVmax values.
Thus, a SUVmax of < 4.4 may be helpful in determining
that a solid type tumor is well-differentiated and non-
invasive. However, the sensitivity for tumor invasiveness
is only 55% at this cutoff value, meaning that PET/CT
cannot absolutely exclude invasiveness. Therefore, an
additional diagnostic method is necessary to increase
the accuracy of this evaluation. It is important to note
that adenocarcinomas with SUVmax values of ≥ 4.4 are
so highly invasive that they are unsuitable for limited
resection. In the study of Ohtsuka et al., patients with
Stage I lung adenocarcinomas showing an SUVmax
of ≥ 3.3 had poorer disease-free survival than those
with an SUVmax <3.3, for patients with Stage I [14].
Turning our attention to subsolid tumors, the C/T ratio
cutoff was found to be 53%. This is consistent with previ-
ous studies concluding that a C/T ratio < 50% is consistent
with a non-invasive tumor [4,6,7]. As the sensitivity for
tumor invasiveness is 89% at this cutoff, high C/T ratio
tumors are unsuitable for limited resection.
This study has 3 limitations, the first of which is its
retrospective and single-center nature. Second, we did not
investigate histopathologic types other than adenocarcin-
oma; squamous cell carcinoma and large cell carcinoma
are generally solid on TSCT and have a higher SUVmax
than adenocarcinoma on PET/CT. Third, the PET/CT
scans were acquired 50 minutes after the injection of FDG
according to the protocol of our institution. This is some-
what early phase and may have influence on the value of
SUVmax.
Conclusions
In conclusion, both the C/T ratio on TSCT and the
SUVmax value on PET/CT are significantly associated
with the level of invasiveness in small adenocarcinomas.
These measures are superior to tumor size for predicting
tumor invasiveness. However, there is a difference between
the 2 evaluations: SUVmax and C/T ratio were significantly
associated with invasiveness of solid type adenocarcinoma
and subsolid type adenocarcinoma, respectively. Thus, the
C/T ratio should be evaluated first, and then SUVmaxshould be used to predict invasiveness only in patients with
solid type tumors.
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